BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34010422)

  • 21. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
    Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
    BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.
    Sapisochin G; de Lope CR; Gastaca M; de Urbina JO; López-Andujar R; Palacios F; Ramos E; Fabregat J; Castroagudín JF; Varo E; Pons JA; Parrilla P; González-Diéguez ML; Rodriguez M; Otero A; Vazquez MA; Zozaya G; Herrero JI; Antolin GS; Perez B; Ciria R; Rufian S; Fundora Y; Ferron JA; Guiberteau A; Blanco G; Varona MA; Barrera MA; Suarez MA; Santoyo J; Bruix J; Charco R
    Ann Surg; 2014 May; 259(5):944-52. PubMed ID: 24441817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of Wait-List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates.
    Ziogas IA; Hickman LA; Matsuoka LK; Izzy M; Montenovo MI; Rega SA; Feurer ID; Alexopoulos SP
    Liver Transpl; 2020 Sep; 26(9):1112-1120. PubMed ID: 32475062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016.
    Comoz B; Ollivier-Hourmand I; Bouvier AM; Nousbaum JB; Nguyen TTN; Launoy G; Bouvier V; Bryere J
    Liver Int; 2024 Feb; 44(2):446-453. PubMed ID: 38010978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Survival of Combined Hepatocellular-Cholangiocarcinoma: A Nationwide Study.
    Chen PD; Chen LJ; Chang YJ; Chang YJ
    Oncologist; 2021 Oct; 26(10):e1774-e1785. PubMed ID: 34213048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological classification of liver and intrahepatic bile duct cancers in SEER registries.
    Altekruse SF; Devesa SS; Dickie LA; McGlynn KA; Kleiner DE
    J Registry Manag; 2011; 38(4):201-5. PubMed ID: 23270094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study.
    Ramai D; Ofosu A; Lai JK; Reddy M; Adler DG
    Am J Gastroenterol; 2019 Sep; 114(9):1496-1501. PubMed ID: 31335362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?
    Zhou Q; Cai H; Xu MH; Ye Y; Li XL; Shi GM; Huang C; Zhu XD; Cai JB; Zhou J; Fan J; Ji Y; Sun HC; Shen YH
    Hepatobiliary Pancreat Dis Int; 2021 Feb; 20(1):13-20. PubMed ID: 33160852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
    Saha SK; Zhu AX; Fuchs CS; Brooks GA
    Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].
    Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS
    Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany].
    Schurr R; Stölzel U; Schuppan D; Schwertner C; Steinberg J; Scherübl H
    Dtsch Med Wochenschr; 2006 Jul; 131(30):1649-55. PubMed ID: 16850381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.
    Luke C; Price T; Roder D
    Asian Pac J Cancer Prev; 2010; 11(6):1479-85. PubMed ID: 21338184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis.
    Yang JD; Luu M; Singal AG; Noureddin M; Kuo A; Ayoub WS; Sundaram V; Kotler H; Kim IK; Todo T; Voidonikolas G; Brennan TV; Kosari K; Klein AS; Hendifar A; Lu SC; Nissen NN; Gong J
    J Natl Compr Canc Netw; 2020 Sep; 18(9):1210-1220. PubMed ID: 32886898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathology of hepatocellular carcinoma.
    Schlageter M; Terracciano LM; D'Angelo S; Sorrentino P
    World J Gastroenterol; 2014 Nov; 20(43):15955-64. PubMed ID: 25473149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.